DIrect Oral Anticoagulation and mechaNical Aortic Valve
Condition:   Aortic Valve Disease Interventions:   Drug: Apixaban 5 MG Oral Tablet;   Drug: warfarin with an objective of INR target of 2.5 (range: 2.0-3.0) Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2023 Category: Research Source Type: clinical trials

Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Condition:   Antiphospholipid Syndrome Interventions:   Drug: Telitacicept;   Drug: Rituximab;   Drug: Aspirin;   Drug: Warfarin;   Drug: Hydroxychloroquine;   Drug: Prednisone Sponsor:   Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials